Beacon Pharmaceuticals Ltd------- Prospectus
Beacon Pharmaceuticals Ltd------- Prospectus
Beacon Pharmaceuticals Ltd------- Prospectus
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Light for Life<br />
BEACON<br />
'If you have any query about this document, you may consult issuer, issue manager and underwriter'<br />
<strong>Prospectus</strong><br />
Public offer of 30,000,000 ordinary shares of Tk. 10.00 each at par<br />
Totaling Tk. 300,000,000.00<br />
Of<br />
BEACON PHARMACEUTICALS LIMITED<br />
Opening date for subscription: 20.06.2010<br />
Closing date for subscription: 24.06.2010<br />
For Non-Resident Bangladeshi quota, subscription closes on: 03.07.2010<br />
Manager(s) to the Issue<br />
Issue Manager<br />
ICB Capital Management Limited<br />
(A Subsidiary of ICB)<br />
BSB Building (14th Floor),<br />
8, DIT Avenue, Dhaka.<br />
Co-Issue Manager<br />
Janata Bank Limited<br />
110, Motijheel C/A<br />
Dhaka-1000.<br />
Underwriters<br />
IDLC Finance Limited<br />
Lanka Bangla Finance Limited<br />
Janata Bank Limited<br />
IIDFC Capital Limited<br />
ICB Capital Management Limited<br />
Issue Date of <strong>Prospectus</strong>: 05.05.2010<br />
The Issue shall be placed in "N" Category<br />
BEACON PHARMACEUTICALS LIMITED<br />
153-154 Tejgaon I/A, Dhaka- 1208<br />
Tel.9888176, 8822543 Fax-88028829314<br />
Email: beacon@beacon-pharma.com<br />
Website: www.beacon-pharma.com<br />
"CONSENT OF THE SECURITIES AND EXCHANGE COMMISSION HAS BEEN OBTAINED TO THE ISSUE/OFFER OF THESE<br />
SECURITIES UNDER THE SECURITIES AND EXCHANGE ORDINANCE, 1969, AND THE SECURITIES AND EXCHANGE<br />
COMMISSION (PUBLIC ISSUE) RULES, 2006. IT MUST BE DISTINCTLY UNDERSTOOD THAT IN GIVING THIS CONSENT<br />
THE COMMISSION DOES NOT TAKE ANY RESPONSIBILITY FOR THE FINANCIAL SOUNDNESS OF THE ISSUER COMPANY,<br />
ANY OF ITS PROJECTS OR THE ISSUE PRICE OF ITS SECURITIES OR FOR THE CORRECTNESS OF ANY OF THE<br />
STATEMENTS MADE OR OPINION EXPRESSED WITH REGARD TO THEM. SUCH RESPONSIBILITY LIES WITH THE ISSUER,<br />
ITS DIRECTORS, CHIEF EXECUTIVE OFFICER/CHIEF FINANCIAL OFFICER, ISSUE MANAGER, UNDERWRITER AND/OR<br />
AUDITOR".<br />
PROSPECTUS